News > Covaxin 'extremely suitable' for low, middle-income countries due to easy storage requirements: WHO
Covaxin 'extremely suitable' for low, middle-income countries due to easy storage requirements: WHO
Times of India | 04/11/2021 12:45 PM | Click to read full article
The World Health Organisation (WHO) has said that the Covaxin-COVID-19 vaccine developed by Bharat Biotech is extremely suitable for low and middle-income countries due to easy storage requirements.
The UN health body-which granted approval for Emergency Use Listing (EUL) of Covaxin on Wednesday-said that the Bharat Biotech's vaccine was found to have 78 per cent efficacy against the COVID-19 of any severity, 14 or more days after the second dose.
